KUALA LUMPUR, Jan 6 -- Guangzhou Pharmaceutical Group (Macau) International Development Co Ltd (the company) has been established by Guangzhou Pharmaceutical Holdings Limited (GPHL), in cooperation with Guangdong Namyue Group and True Point Global Limited, in Macau recently.
Positioned as a platform for GPHL's international business, it is committed to being a new growth pole with international competitiveness to take a lead in the Guangdong-Hong Kong-Macau Greater Bay Area while covering Southeast Asia and Portuguese-speaking countries.
It aims to deepen the pharmaceutical cooperation in the Area and promote the moderately diversified economic development of Macau and accelerate the internationalisation layout of GPHL, according to a statement.
According to the planning, the international headquarters of GPHL in Macau will promote the formation of industrial alliance under the guidance of ‘one country, two systems’, ‘one company, two places’ and ‘one product, two selling markets’.
The ‘two systems’ help to accelerate the GPHL's going-global strategy with institutional strengths. With its base in Guangzhou and international headquarters in Macau, it can better exploit the resource advantages in these ‘two places’.
For future development of its international headquarters, GPHL also established Guangzhou Pharmaceutical (Hengqin) Medicine Industrial Park Co Ltd in the TCM Science and Technology Industrial Park of Co-operation between Guangdong and Macau (GMTCM Park).
Serving as a platform for pharmaceutical R&D and industrialisation, it will introduce new projects including R&D, pharmaceutical supply chain and Chinese Medicine extraction to help GPHL involve into a world-class enterprise.
-- BERNAMA
No comments:
Post a Comment